This calls for the need to search out a safer treatment regimen which in addition to their antimalarial effect, will also improve the antioxidant status and hematological indices of G6PD-deficient and sickle cell patients suffering from malaria, thereby protecting them from oxidative stress and anemia. Here, G6PD is linked to anemia.